Gilead Sciences Inc (GILD)

Return on assets (ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands 480,000 126,000 1,053,000 484,000 5,664,000 5,875,000 5,484,000 5,583,000 4,585,000 3,327,000 4,130,000 4,508,000 6,225,000 7,394,000 5,162,000 301,000 123,000 1,268,000 -257,000 4,962,000
Total assets US$ in thousands 58,995,000 54,525,000 53,579,000 56,292,000 62,125,000 62,373,000 62,337,000 61,876,000 63,171,000 62,557,000 62,870,000 63,080,000 67,952,000 67,098,000 67,984,000 67,492,000 68,407,000 60,878,000 55,934,000 59,741,000
ROA 0.81% 0.23% 1.97% 0.86% 9.12% 9.42% 8.80% 9.02% 7.26% 5.32% 6.57% 7.15% 9.16% 11.02% 7.59% 0.45% 0.18% 2.08% -0.46% 8.31%

December 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $480,000K ÷ $58,995,000K
= 0.81%

The return on assets (ROA) of Gilead Sciences Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The ROA started at 8.31% in March 2020 and experienced a decline to -0.46% in June 2020, indicating a period of inefficiency in asset utilization. However, the company managed to improve its ROA gradually, reaching 11.02% in September 2021, which was the highest point during the period analyzed.

Subsequently, the ROA maintained a range between 5% to 9%, with slight fluctuations, and ended at 0.81% in December 2024. This suggests that the company was able to generate a moderate return relative to its total assets in the later period.

Overall, Gilead Sciences Inc's ROA performance indicates variability but generally improved asset efficiency and profitability over the analyzed period, with occasional fluctuations likely influenced by factors such as business operations, investments, and economic conditions.


See also:

Gilead Sciences Inc Return on Assets (ROA) (Quarterly Data)